When you finish a course of medicine, you expect to get better. But doctors in New York City are sharing an observation that's making them look closer: some patients treated for mpox with the antiviral drug tecovirimat later developed new skin lesions. This is a report from the field, a note from clinicians about what they are seeing in their patients after treatment ended. The report simply describes that these post-treatment lesions happened. It doesn't tell us how many patients were affected, how severe the lesions were, or if they were directly caused by the treatment or the virus itself. There's no information on other side effects or how patients ultimately fared. Because this is a descriptive report and not a controlled study, it can't prove anything. It serves as an alert for other doctors to pay attention to this possibility in their own patients recovering from mpox.
Field report describes posttreatment lesions after tecovirimat therapy for mpox in New York CityWhat happens after mpox treatment? Doctors describe lingering skin lesions
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: A single field report describes posttreatment lesions after tecovirimat for mpox; controlled data are needed.
A field report from New York City describes the occurrence of posttreatment lesions in patients with mpox who received tecovirimat therapy. The report does not specify the study phase, sample size, comparator group, or primary outcome measures. No quantitative results, effect sizes, or statistical measures are provided; the finding is described qualitatively as 'posttreatment lesions were described'.
No safety or tolerability data, including adverse events, serious adverse events, or treatment discontinuations, are reported. The report does not list specific methodological limitations, but the absence of a comparator, sample size, and quantitative outcomes are inherent constraints.
Given the descriptive nature of this single field report, the clinical relevance for practice is not established. This observation should be interpreted as a potential signal requiring investigation in formal studies with defined populations, controls, and outcome measures before any conclusions about tecovirimat and posttreatment lesions can be drawn.
What this means for you:
Doctors report new skin lesions in some mpox patients after antiviral treatment. More on Mpox
Case series finds no adverse reaction to tecovirimat in four pregnant persons with mpox
Is the mpox treatment safe for pregnant people? Early data shows no adverse reactions
A U.S. surveillance case series of mpox in cisgender women reported no adverse reaction to tecovirimat in four treated pregnant persons.
Early data on pregnant people treated for mpox shows no adverse reactions to the antiviral drug tecovirimat, offering a small but valuable p…
Tecovirimat distribution reported during Los Angeles County mpox outbreak
How did Los Angeles County distribute mpox treatment during the outbreak?
A report describes tecovirimat distribution during the 2022-23 mpox outbreak in Los Angeles County.
A new report details how Los Angeles County distributed the antiviral drug tecovirimat to treat mpox patients during the 2022-23 outbreak.
LC16m8 pre-exposure prophylaxis showed no mpox cases in a randomized controlled trial of high-risk adults
Mpox Vaccine Shows Promise for High-Risk Groups, But Key Questions Remain
This randomized controlled trial enrolled 570 participants in an early-vaccination group and 565 in a late-vaccination group. No mpox cases …
A new mpox vaccine produced strong immune responses in high-risk individuals, including those with HIV, but researchers still can't say for …
Technical report validates AI tool for classifying MPXV subclades using genomic data
New AI tool quickly identifies dangerous mpox virus types from DNA samples
This technical report describes a methodological development for a software tool called CladePredictor-MPXV.
This new AI tool sorts mpox virus types in seconds and helps doctors track dangerous outbreaks faster than ever before
View Original Abstract ↓
This report describes treatment of lesions following completion of tecovirimat therapy for mpox.
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
FDA Approves Linezolid Injection for Gram-Positive Infections Including Pneumonia and Skin Infections
FDA approves new antibiotic injection for serious bacterial infections
The FDA approved linezolid injection for nosocomial pneumonia, community-acquired pneumonia, complicated skin infections, and vancomycin-res…
The FDA approved linezolid injection for treating serious infections like pneumonia and skin infections caused by certain bacteria, includin…
Intrawound vancomycin powder reduces postoperative infection risk (OR 0.59) in high-risk fracture fixation cases
Vancomycin Powder May Reduce Infections After High Risk Fractures
This meta-analysis of 3185 patients found that intrawound vancomycin powder significantly reduced postoperative infection rates (OR 0.59; 95…
A review of data suggests that using vancomycin powder in wounds may lower infection rates for patients with serious bone fractures.
Risk-adapted HLA delisting and imlifidase enable deceased-donor kidney transplantation for highly sensitized candidates
New guide helps transplant kidneys for hardest-to-match patients
This expert consensus provides a practical guideline for managing highly sensitized adult patients on the waitlist for deceased-donor kidney…
A new expert guide shows how to safely transplant kidneys into highly sensitized patients who have few options left.
Regenerative endodontic procedures may lead to unusual root morphology in immature teeth
Regenerative procedures can lead to unusual tooth root growth
This case report with literature review describes 2 immature teeth with pulp necrosis secondary to dens evaginatus treated with regenerative…
A new look at dental treatments shows that while some procedures save teeth, they can sometimes cause unexpected changes in how roots grow.
From Other Specialties
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …